Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative ...

Palm Beach Gardens, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel ...

Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc ...

Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc ...

Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel ...

"Druggable Target to Treat Retinal Degeneration" Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Company"), a company developing ...

Boca Raton, FL, April 29, 2021 (GLOBE NEWSWIRE) -- CurativeBiotechnology,Inc. (OTC: CUBT) a development stage biomedical company focused on novel therapies for rare diseases, announced today the ...

Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Dr. Theresa Heah is an accomplished executive who brings over two ...

Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Dr. Heah has led multiple successful global ophthalmic innovation, ...

The Application has been accorded International Application No.: PCT/US23/23094. Interested investors and shareholders can be notified of future Press releases and Industry Updates by e-mailing ...